Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Corium International, Inc. (CORI)

Add CORI Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/1/2017 8:53:52 PM - Followers: 7 - Board type: Free - Posts Today: 0

Corium International, Inc. 235 Constitution Drive Menlo Park, CA 94025 United States Phone: 650-298-8255 Fax: 650-298-8012 Website: Corium International, Inc., a biopharmaceutical company, focuses on the research, development, manufacture, and commercialization of specialty pharmaceutical products. Its products include Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for management of chronic pain, including cancer-related pain; Crest Whitestrips, a series of four products under the Advanced Vivid, Professional Effects, One Hour Express, and Flex-Fit brands for oral care. The company is also developing AG200-15, a combination hormonal contraceptive patch in Phase III clinical trials that delivers ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system, which has completed Phase I clinical trials for the treatment of severe osteoporosis; and Corplex Tamsulosin that has completed Phase I clinical trials for the treatment of benign prostatic hyperplasia. In addition, its products that have completed development, scale-up, and clinical activities include motion sickness patch for the prevention of nausea and vomiting associated with motion sickness; and urology patch for treatment of a urologic condition. Further, the company is developing Donepezil and Memantine transdermal patches for the treatment of Alzheimer's disease; and Ropinerole and Pramipexole therapies for the treatment of Parkinson's disease. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company, Teva Pharmaceuticals USA, Inc., Par Pharmaceutical, Inc., and Agile Therapeutics, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CORI News: Corium to Join NASDAQ Biotechnology Index 12/12/2017 07:30:00 AM
CORI News: Statement of Changes in Beneficial Ownership (4) 11/17/2017 04:26:35 PM
CORI News: Current Report Filing (8-k) 11/16/2017 04:17:00 PM
CORI News: Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights 11/16/2017 04:02:00 PM
CORI News: Corium to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, November 16, 2017 11/09/2017 08:00:00 AM
#13   Why are you buying here seems overbought to me Rogerthat1 06/01/17 08:53:52 PM
#12   1% gain two days: sold soon after Open, Frugivore 06/01/17 10:53:38 AM
#11   $CORI Bought to Open (BTO) @ $7.41 Frugivore 05/30/17 05:46:25 PM
#10   $CORI Sold STC @ $6.72 for intraday 3% gain. Frugivore 05/25/17 04:18:51 PM
#8   $CORI Opened new position BTO @ $6.50 after Frugivore 05/25/17 02:45:06 PM
#7   ALL IN 2 17 gregque 05/13/17 02:21:19 PM
#6   RTW INVESTMENTS, LLC has filed a new 13G, wiltonio 05/05/17 05:14:01 PM
#5   $CORI 4$ :-D Cbdpotential 04/09/17 12:37:04 PM
#4   * * $CORI Video Chart 02-15-17 * * ClayTrader 02/15/17 05:06:30 PM
#3   Corium International, Inc. just filed a prospectus, suggesting guchu 02/03/17 09:12:13 AM
#2   Corium Internation (CORI) Prices 6.67M Shares at $3 guchu 02/03/17 09:11:50 AM
#1   $CORI recent news/filings stocktrademan 11/16/15 02:18:43 PM